Industry Context — Common BS Fingerprints in Medical Devices, Pharma & Biotech
Purdue Pharma L.P.
(https://purduepharma.com) 📸 Data Snapshot: June 19, 2026Analyze the raw signals below. How would a machine score this business’s credibility?
Here are the exact signals captured from up to six pages of the site — the same raw inputs the evaluation engine analyzed. They are grouped by signal type so you can weigh each the way the machine does.
🏗️ Semantic Structure — heading hierarchy & page identity (Info Density · Commodity Fingerprint)
HOMEPAGE Purdue Pharma (https://purduepharma.com)
Purdue Pharma
Purdue Pharma and its subsidiaries are physician-founded and physician-led companies that develop, manufacture and market medications and consumer health products to meet the evolving needs of healthcare professionals, patients, consumers and caregivers. Purdue Pharma is also committed to supporting national, regional and local collaborations to drive innovations in patient care while continuing our efforts to address the opioid addiction crisis.
NAV_HEADER_HEADING_REPEATED_BODY Purdue Pharma (https://purduepharma.com/careers-at-purdue/)
Purdue Pharma
Purdue Pharma and its subsidiaries are physician-founded and physician-led companies that develop, manufacture and market medications and consumer health products to meet the evolving needs of healthcare professionals, patients, consumers and caregivers. Purdue Pharma is also committed to supporting national, regional and local collaborations to drive innovations in patient care while continuing our efforts to address the opioid addiction crisis.
NAV_HEADER_HEADING_REPEATED_BODY Purdue Pharma (https://purduepharma.com/healthcare-professionals/)
Purdue Pharma
Purdue Pharma and its subsidiaries are physician-founded and physician-led companies that develop, manufacture and market medications and consumer health products to meet the evolving needs of healthcare professionals, patients, consumers and caregivers. Purdue Pharma is also committed to supporting national, regional and local collaborations to drive innovations in patient care while continuing our efforts to address the opioid addiction crisis.
NAV_HEADER_HEADING_REPEATED_BODY Purdue Pharma (https://purduepharma.com/patients-caregivers/)
Purdue Pharma
Purdue Pharma and its subsidiaries are physician-founded and physician-led companies that develop, manufacture and market medications and consumer health products to meet the evolving needs of healthcare professionals, patients, consumers and caregivers. Purdue Pharma is also committed to supporting national, regional and local collaborations to drive innovations in patient care while continuing our efforts to address the opioid addiction crisis.
📝 The Narrative — clean text per page (Info Density · Semantic Coherence)
HOMEPAGE (https://purduepharma.com) Purdue Pharma
[H2] Restructure Information On May 1, 2026, Purdue Pharma permanently ceased operations. Knoa Pharma, a new and different company, will distribute medicines formerly distributed by Purdue Pharma. Click here to be taken to the Knoa Pharma website. Information relating to the Purdue Pharma Bankruptcy can be found here: Kroll Restructuring Administration, or by calling 844.217.0912 (Toll-Free). [H1] patient-first approach in developing medicines LEARN MORE [H1] Here to Answer Your Questions LEARN MORE [H1] The Things We Care About LEARN MORE [H1] JOIN OUR TEAM LEARN MORE [H1] Committed to Supporting Compassionate Care LEARN MORE [H2] RECENT NEWS [H2] GCAR and Purdue Pharma L.P. Announce Initiation of Tinostamustine in GBM AGILE Trial Tinostamustine Now Enrolling in GBM AGILE, a Registrational-Intent Phase 2/3 Adaptive Platform Trial for Patients with Glioblastoma LARKSPUR, Calif. and STAMFORD, CT, April 8, 2026 /PRNewswire/ –… [H2] Tinostamustine Shows Early Signals of Activity in Phase 1 Glioblastoma Trial Data reveals positive preliminary results for investigational agent tinostamustine as a potential first-in-class treatment for glioblastoma. Stamford, Conn. November 19, 2025 – Purdue Pharma L.P.… MORE NEWS [IMG: featured-image_OSU-01] [H3] Nikki’s House: Supporting Women in Recovery In 2017, Nicole Wesley, MD, MBA, MHA, lost her father to congestive heart failure. When she inherited his home in Warren, Ohio, Nicole knew she could do something special with it. Five months later, Nikki’s House – a recovery home for women healing from substance use disorder – opened its doors to the first two women. Five years later, Nikki’s House has given approximately 250 women the opportunity to live sober lives. Read More [IMG: featured-image_Roby-01] [H3] Move Together, Heal Together Ethan Hershman has been in recovery from substance use disorder for 28 years. While he’s never once relapsed, he’s seen his fair share of people who haven’t been as fortunate and, in many tragic cases, have lost their lives. He finally asked himself, “why?” Read More [IMG: featured-image_ORII-hands-01] [H3] Renewal House: Keeping Families Together and Creating Bright Futures for Women and Children Mothers seeking treatment for substance use disorder often must choose between taking care of their children and taking care of themselves. Renewal House is offering mothers in Middle Tennessee a different option – one where they don’t have to choose. Read More TERMS & CONDITIONS LOCATION & OPERATIONS CONTACT US REPORT AN ADVERSE EVENT ASK PURDUE MEDICAL DO NOT SELL MY INFORMATION ETHICS & COMPLIANCE SITE MAP PATIENT SAVINGS PROGRAM Purdue Privacy Policy/Data Rights Request
SUB-PAGE (https://purduepharma.com/careers-at-purdue/) Purdue Pharma
[H2] Restructure Information On May 1, 2026, Purdue Pharma permanently ceased operations. Knoa Pharma, a new and different company, will distribute medicines formerly distributed by Purdue Pharma. Click here to be taken to the Knoa Pharma website. Information relating to the Purdue Pharma Bankruptcy can be found here: Kroll Restructuring Administration, or by calling 844.217.0912 (Toll-Free). [H1] patient-first approach in developing medicines LEARN MORE [H1] Here to Answer Your Questions LEARN MORE [H1] The Things We Care About LEARN MORE [H1] JOIN OUR TEAM LEARN MORE [H1] Committed to Supporting Compassionate Care LEARN MORE [H2] RECENT NEWS [H2] GCAR and Purdue Pharma L.P. Announce Initiation of Tinostamustine in GBM AGILE Trial Tinostamustine Now Enrolling in GBM AGILE, a Registrational-Intent Phase 2/3 Adaptive Platform Trial for Patients with Glioblastoma LARKSPUR, Calif. and STAMFORD, CT, April 8, 2026 /PRNewswire/ –… [H2] Tinostamustine Shows Early Signals of Activity in Phase 1 Glioblastoma Trial Data reveals positive preliminary results for investigational agent tinostamustine as a potential first-in-class treatment for glioblastoma. Stamford, Conn. November 19, 2025 – Purdue Pharma L.P.… MORE NEWS [IMG: featured-image_OSU-01] [H3] Nikki’s House: Supporting Women in Recovery In 2017, Nicole Wesley, MD, MBA, MHA, lost her father to congestive heart failure. When she inherited his home in Warren, Ohio, Nicole knew she could do something special with it. Five months later, Nikki’s House – a recovery home for women healing from substance use disorder – opened its doors to the first two women. Five years later, Nikki’s House has given approximately 250 women the opportunity to live sober lives. Read More [IMG: featured-image_Roby-01] [H3] Move Together, Heal Together Ethan Hershman has been in recovery from substance use disorder for 28 years. While he’s never once relapsed, he’s seen his fair share of people who haven’t been as fortunate and, in many tragic cases, have lost their lives. He finally asked himself, “why?” Read More [IMG: featured-image_ORII-hands-01] [H3] Renewal House: Keeping Families Together and Creating Bright Futures for Women and Children Mothers seeking treatment for substance use disorder often must choose between taking care of their children and taking care of themselves. Renewal House is offering mothers in Middle Tennessee a different option – one where they don’t have to choose. Read More TERMS & CONDITIONS LOCATION & OPERATIONS CONTACT US REPORT AN ADVERSE EVENT ASK PURDUE MEDICAL DO NOT SELL MY INFORMATION ETHICS & COMPLIANCE SITE MAP PATIENT SAVINGS PROGRAM Purdue Privacy Policy/Data Rights Request
SUB-PAGE (https://purduepharma.com/healthcare-professionals/) Purdue Pharma
[H2] Restructure Information On May 1, 2026, Purdue Pharma permanently ceased operations. Knoa Pharma, a new and different company, will distribute medicines formerly distributed by Purdue Pharma. Click here to be taken to the Knoa Pharma website. Information relating to the Purdue Pharma Bankruptcy can be found here: Kroll Restructuring Administration, or by calling 844.217.0912 (Toll-Free). [H1] patient-first approach in developing medicines LEARN MORE [H1] Here to Answer Your Questions LEARN MORE [H1] The Things We Care About LEARN MORE [H1] JOIN OUR TEAM LEARN MORE [H1] Committed to Supporting Compassionate Care LEARN MORE [H2] RECENT NEWS [H2] GCAR and Purdue Pharma L.P. Announce Initiation of Tinostamustine in GBM AGILE Trial Tinostamustine Now Enrolling in GBM AGILE, a Registrational-Intent Phase 2/3 Adaptive Platform Trial for Patients with Glioblastoma LARKSPUR, Calif. and STAMFORD, CT, April 8, 2026 /PRNewswire/ –… [H2] Tinostamustine Shows Early Signals of Activity in Phase 1 Glioblastoma Trial Data reveals positive preliminary results for investigational agent tinostamustine as a potential first-in-class treatment for glioblastoma. Stamford, Conn. November 19, 2025 – Purdue Pharma L.P.… MORE NEWS [IMG: featured-image_OSU-01] [H3] Nikki’s House: Supporting Women in Recovery In 2017, Nicole Wesley, MD, MBA, MHA, lost her father to congestive heart failure. When she inherited his home in Warren, Ohio, Nicole knew she could do something special with it. Five months later, Nikki’s House – a recovery home for women healing from substance use disorder – opened its doors to the first two women. Five years later, Nikki’s House has given approximately 250 women the opportunity to live sober lives. Read More [IMG: featured-image_Roby-01] [H3] Move Together, Heal Together Ethan Hershman has been in recovery from substance use disorder for 28 years. While he’s never once relapsed, he’s seen his fair share of people who haven’t been as fortunate and, in many tragic cases, have lost their lives. He finally asked himself, “why?” Read More [IMG: featured-image_ORII-hands-01] [H3] Renewal House: Keeping Families Together and Creating Bright Futures for Women and Children Mothers seeking treatment for substance use disorder often must choose between taking care of their children and taking care of themselves. Renewal House is offering mothers in Middle Tennessee a different option – one where they don’t have to choose. Read More TERMS & CONDITIONS LOCATION & OPERATIONS CONTACT US REPORT AN ADVERSE EVENT ASK PURDUE MEDICAL DO NOT SELL MY INFORMATION ETHICS & COMPLIANCE SITE MAP PATIENT SAVINGS PROGRAM Purdue Privacy Policy/Data Rights Request
SUB-PAGE (https://purduepharma.com/patients-caregivers/) Purdue Pharma
[H2] Restructure Information On May 1, 2026, Purdue Pharma permanently ceased operations. Knoa Pharma, a new and different company, will distribute medicines formerly distributed by Purdue Pharma. Click here to be taken to the Knoa Pharma website. Information relating to the Purdue Pharma Bankruptcy can be found here: Kroll Restructuring Administration, or by calling 844.217.0912 (Toll-Free). [H1] patient-first approach in developing medicines LEARN MORE [H1] Here to Answer Your Questions LEARN MORE [H1] The Things We Care About LEARN MORE [H1] JOIN OUR TEAM LEARN MORE [H1] Committed to Supporting Compassionate Care LEARN MORE [H2] RECENT NEWS [H2] GCAR and Purdue Pharma L.P. Announce Initiation of Tinostamustine in GBM AGILE Trial Tinostamustine Now Enrolling in GBM AGILE, a Registrational-Intent Phase 2/3 Adaptive Platform Trial for Patients with Glioblastoma LARKSPUR, Calif. and STAMFORD, CT, April 8, 2026 /PRNewswire/ –… [H2] Tinostamustine Shows Early Signals of Activity in Phase 1 Glioblastoma Trial Data reveals positive preliminary results for investigational agent tinostamustine as a potential first-in-class treatment for glioblastoma. Stamford, Conn. November 19, 2025 – Purdue Pharma L.P.… MORE NEWS [IMG: featured-image_OSU-01] [H3] Nikki’s House: Supporting Women in Recovery In 2017, Nicole Wesley, MD, MBA, MHA, lost her father to congestive heart failure. When she inherited his home in Warren, Ohio, Nicole knew she could do something special with it. Five months later, Nikki’s House – a recovery home for women healing from substance use disorder – opened its doors to the first two women. Five years later, Nikki’s House has given approximately 250 women the opportunity to live sober lives. Read More [IMG: featured-image_Roby-01] [H3] Move Together, Heal Together Ethan Hershman has been in recovery from substance use disorder for 28 years. While he’s never once relapsed, he’s seen his fair share of people who haven’t been as fortunate and, in many tragic cases, have lost their lives. He finally asked himself, “why?” Read More [IMG: featured-image_ORII-hands-01] [H3] Renewal House: Keeping Families Together and Creating Bright Futures for Women and Children Mothers seeking treatment for substance use disorder often must choose between taking care of their children and taking care of themselves. Renewal House is offering mothers in Middle Tennessee a different option – one where they don’t have to choose. Read More TERMS & CONDITIONS LOCATION & OPERATIONS CONTACT US REPORT AN ADVERSE EVENT ASK PURDUE MEDICAL DO NOT SELL MY INFORMATION ETHICS & COMPLIANCE SITE MAP PATIENT SAVINGS PROGRAM Purdue Privacy Policy/Data Rights Request
🛡️ Trust Signals — reviews, proof links, trust-theatre flag (Trust & Proof)
| Page | Reviews | Proof links |
|---|---|---|
| / (home) | 2 | 0 |
| /careers-at-purdue/ | 2 | 0 |
| /healthcare-professionals/ | 2 | 0 |
| /patients-caregivers/ | 2 | 0 |
🔗 Identity & Technical Layer — schema JSON-LD: identity chains, entity gaps (Identity & Authority)
Homepage schema
{
"@context": "https://schema.org",
"@graph": [
{
"@type": "WebPage",
"@id": "https://www.purduepharma.com/",
"url": "https://www.purduepharma.com/",
"name": "Purdue Pharma",
"isPartOf": {
"@id": "https://www.purduepharma.com/#website"
},
"about": {
"@id": "https://www.purduepharma.com/#organization"
},
"datePublished": "2018-06-25T21:44:54+00:00",
"dateModified": "2026-05-14T15:18:47+00:00",
"description": "Purdue Pharma and its subsidiaries are physician-founded and physician-led companies that develop, manufacture and market medications and consumer health products to meet the evolving needs of healthcare professionals, patients, consumers and caregivers. Purdue Pharma is also committed to supporting national, regional and local collaborations to drive innovations in patient care while continuing our efforts to address the opioid addiction crisis.",
"breadcrumb": {
"@id": "https://www.purduepharma.com/#breadcrumb"
},
"inLanguage": "en-US",
"potentialAction": [
{
"@type": "ReadAction",
"target": [
"https://www.purduepharma.com/"
]
}
]
},
{
"@type": "BreadcrumbList",
"@id": "https://www.purduepharma.com/#breadcrumb",
"itemListElement": [
{
"@type": "ListItem",
"position": 1,
"name": "Home"
}
]
},
{
"@type": "WebSite",
"@id": "https://www.purduepharma.com/#website",
"url": "https://www.purduepharma.com/",
"name": "Purdue Pharma",
"description": "",
"publisher": {
"@id": "https://www.purduepharma.com/#organization"
},
"potentialAction": [
{
"@type": "SearchAction",
"target": {
"@type": "EntryPoint",
"urlTemplate": "https://www.purduepharma.com/?s={search_term_string}"
},
"query-input": {
"@type": "PropertyValueSpecification",
"valueRequired": true,
"valueName": "search_term_string"
}
}
],
"inLanguage": "en-US"
},
{
"@type": "Organization",
"@id": "https://www.purduepharma.com/#organization",
"name": "Purdue Pharma L.P.",
"url": "https://www.purduepharma.com/",
"logo": {
"@type": "ImageObject",
"inLanguage": "en-US",
"@id": "https://www.purduepharma.com/#/schema/logo/image/",
"url": "http://3.229.236.200/wp-content/uploads/2019/05/purdue-logo.jpg",
"contentUrl": "http://3.229.236.200/wp-content/uploads/2019/05/purdue-logo.jpg",
"width": 190,
"height": 87,
"caption": "Purdue Pharma L.P."
},
"image": {
"@id": "https://www.purduepharma.com/#/schema/logo/image/"
}
}
]
}
/careers-at-purdue/
{
"@context": "https://schema.org",
"@graph": [
{
"@type": "WebPage",
"@id": "https://www.purduepharma.com/",
"url": "https://www.purduepharma.com/",
"name": "Purdue Pharma",
"isPartOf": {
"@id": "https://www.purduepharma.com/#website"
},
"about": {
"@id": "https://www.purduepharma.com/#organization"
},
"datePublished": "2018-06-25T21:44:54+00:00",
"dateModified": "2026-05-14T15:18:47+00:00",
"description": "Purdue Pharma and its subsidiaries are physician-founded and physician-led companies that develop, manufacture and market medications and consumer health products to meet the evolving needs of healthcare professionals, patients, consumers and caregivers. Purdue Pharma is also committed to supporting national, regional and local collaborations to drive innovations in patient care while continuing our efforts to address the opioid addiction crisis.",
"breadcrumb": {
"@id": "https://www.purduepharma.com/#breadcrumb"
},
"inLanguage": "en-US",
"potentialAction": [
{
"@type": "ReadAction",
"target": [
"https://www.purduepharma.com/"
]
}
]
},
{
"@type": "BreadcrumbList",
"@id": "https://www.purduepharma.com/#breadcrumb",
"itemListElement": [
{
"@type": "ListItem",
"position": 1,
"name": "Home"
}
]
},
{
"@type": "WebSite",
"@id": "https://www.purduepharma.com/#website",
"url": "https://www.purduepharma.com/",
"name": "Purdue Pharma",
"description": "",
"publisher": {
"@id": "https://www.purduepharma.com/#organization"
},
"potentialAction": [
{
"@type": "SearchAction",
"target": {
"@type": "EntryPoint",
"urlTemplate": "https://www.purduepharma.com/?s={search_term_string}"
},
"query-input": {
"@type": "PropertyValueSpecification",
"valueRequired": true,
"valueName": "search_term_string"
}
}
],
"inLanguage": "en-US"
},
{
"@type": "Organization",
"@id": "https://www.purduepharma.com/#organization",
"name": "Purdue Pharma L.P.",
"url": "https://www.purduepharma.com/",
"logo": {
"@type": "ImageObject",
"inLanguage": "en-US",
"@id": "https://www.purduepharma.com/#/schema/logo/image/",
"url": "http://3.229.236.200/wp-content/uploads/2019/05/purdue-logo.jpg",
"contentUrl": "http://3.229.236.200/wp-content/uploads/2019/05/purdue-logo.jpg",
"width": 190,
"height": 87,
"caption": "Purdue Pharma L.P."
},
"image": {
"@id": "https://www.purduepharma.com/#/schema/logo/image/"
}
}
]
}
/healthcare-professionals/
{
"@context": "https://schema.org",
"@graph": [
{
"@type": "WebPage",
"@id": "https://www.purduepharma.com/",
"url": "https://www.purduepharma.com/",
"name": "Purdue Pharma",
"isPartOf": {
"@id": "https://www.purduepharma.com/#website"
},
"about": {
"@id": "https://www.purduepharma.com/#organization"
},
"datePublished": "2018-06-25T21:44:54+00:00",
"dateModified": "2026-05-14T15:18:47+00:00",
"description": "Purdue Pharma and its subsidiaries are physician-founded and physician-led companies that develop, manufacture and market medications and consumer health products to meet the evolving needs of healthcare professionals, patients, consumers and caregivers. Purdue Pharma is also committed to supporting national, regional and local collaborations to drive innovations in patient care while continuing our efforts to address the opioid addiction crisis.",
"breadcrumb": {
"@id": "https://www.purduepharma.com/#breadcrumb"
},
"inLanguage": "en-US",
"potentialAction": [
{
"@type": "ReadAction",
"target": [
"https://www.purduepharma.com/"
]
}
]
},
{
"@type": "BreadcrumbList",
"@id": "https://www.purduepharma.com/#breadcrumb",
"itemListElement": [
{
"@type": "ListItem",
"position": 1,
"name": "Home"
}
]
},
{
"@type": "WebSite",
"@id": "https://www.purduepharma.com/#website",
"url": "https://www.purduepharma.com/",
"name": "Purdue Pharma",
"description": "",
"publisher": {
"@id": "https://www.purduepharma.com/#organization"
},
"potentialAction": [
{
"@type": "SearchAction",
"target": {
"@type": "EntryPoint",
"urlTemplate": "https://www.purduepharma.com/?s={search_term_string}"
},
"query-input": {
"@type": "PropertyValueSpecification",
"valueRequired": true,
"valueName": "search_term_string"
}
}
],
"inLanguage": "en-US"
},
{
"@type": "Organization",
"@id": "https://www.purduepharma.com/#organization",
"name": "Purdue Pharma L.P.",
"url": "https://www.purduepharma.com/",
"logo": {
"@type": "ImageObject",
"inLanguage": "en-US",
"@id": "https://www.purduepharma.com/#/schema/logo/image/",
"url": "http://3.229.236.200/wp-content/uploads/2019/05/purdue-logo.jpg",
"contentUrl": "http://3.229.236.200/wp-content/uploads/2019/05/purdue-logo.jpg",
"width": 190,
"height": 87,
"caption": "Purdue Pharma L.P."
},
"image": {
"@id": "https://www.purduepharma.com/#/schema/logo/image/"
}
}
]
}
/patients-caregivers/
{
"@context": "https://schema.org",
"@graph": [
{
"@type": "WebPage",
"@id": "https://www.purduepharma.com/",
"url": "https://www.purduepharma.com/",
"name": "Purdue Pharma",
"isPartOf": {
"@id": "https://www.purduepharma.com/#website"
},
"about": {
"@id": "https://www.purduepharma.com/#organization"
},
"datePublished": "2018-06-25T21:44:54+00:00",
"dateModified": "2026-05-14T15:18:47+00:00",
"description": "Purdue Pharma and its subsidiaries are physician-founded and physician-led companies that develop, manufacture and market medications and consumer health products to meet the evolving needs of healthcare professionals, patients, consumers and caregivers. Purdue Pharma is also committed to supporting national, regional and local collaborations to drive innovations in patient care while continuing our efforts to address the opioid addiction crisis.",
"breadcrumb": {
"@id": "https://www.purduepharma.com/#breadcrumb"
},
"inLanguage": "en-US",
"potentialAction": [
{
"@type": "ReadAction",
"target": [
"https://www.purduepharma.com/"
]
}
]
},
{
"@type": "BreadcrumbList",
"@id": "https://www.purduepharma.com/#breadcrumb",
"itemListElement": [
{
"@type": "ListItem",
"position": 1,
"name": "Home"
}
]
},
{
"@type": "WebSite",
"@id": "https://www.purduepharma.com/#website",
"url": "https://www.purduepharma.com/",
"name": "Purdue Pharma",
"description": "",
"publisher": {
"@id": "https://www.purduepharma.com/#organization"
},
"potentialAction": [
{
"@type": "SearchAction",
"target": {
"@type": "EntryPoint",
"urlTemplate": "https://www.purduepharma.com/?s={search_term_string}"
},
"query-input": {
"@type": "PropertyValueSpecification",
"valueRequired": true,
"valueName": "search_term_string"
}
}
],
"inLanguage": "en-US"
},
{
"@type": "Organization",
"@id": "https://www.purduepharma.com/#organization",
"name": "Purdue Pharma L.P.",
"url": "https://www.purduepharma.com/",
"logo": {
"@type": "ImageObject",
"inLanguage": "en-US",
"@id": "https://www.purduepharma.com/#/schema/logo/image/",
"url": "http://3.229.236.200/wp-content/uploads/2019/05/purdue-logo.jpg",
"contentUrl": "http://3.229.236.200/wp-content/uploads/2019/05/purdue-logo.jpg",
"width": 190,
"height": 87,
"caption": "Purdue Pharma L.P."
},
"image": {
"@id": "https://www.purduepharma.com/#/schema/logo/image/"
}
}
]
}
Your Diagnosis
Before revealing the machine’s verdict, predict the BS score for each signal. Higher = more BS (more fluff, less verifiable substance). Drag each slider, then submit to compare your judgment against the engine.
Stuck? Reveal the heuristic lens — how the deterministic page-auditor reads each signal (no AI, pure pattern rules)
These are the structural rules a local, deterministic auditor applies — the same lens you can use to judge each signal. They describe what to look for, not this company’s result.
Classify each sentence as substantive or hollow. Grounding markers — numbers, currencies, dates, technical units, named entities — outweigh marketing adjectives. When fluff sits right next to hard evidence, the fluff is forgiven.
Pull the main entities out of the H1, then check whether they actually recur through the body. A page that announces one thing and then talks about another drifts. Headings with no real sentences underneath read as pseudo-substance.
Count trust words (review, testimonial, rating, verified) against real outbound proof links (Google, Trustpilot, Clutch, G2, Yelp). Lots of trust language with zero verification links is trust theatre. Unlinked logo galleries count against it.
Look at how much sentence length varies. Natural writing varies its rhythm; templated or mass-produced copy is statistically uniform. Very low variation reads as commodity content — unless unique named entities break the pattern.
Inspect the JSON-LD. Is there an Organization or Person schema, and does it carry sameAs links to real external profiles (LinkedIn, socials)? Missing schema or no identity declaration signals an anonymous entity.
Want to apply this lens yourself? The free BS Indicator Chrome extension runs these heuristic checks live on any page. Bear in mind it is a single-page, deterministic tool — it relies only on pattern rules for the page in front of it and does not perform the cross-page semantic correlation this audit uses, so its readout is a starting lens, not the full verdict.
Based on 784 businesses audited.
Medical Devices, Pharma & Biotech BS: Purdue Pharma L.P. (purduepharma.com)
Purdue Pharma is a corporate ghost ship, maintaining a digital presence that markets innovation while its primary headlines announce its operational death. The 100% content duplication across the site map signals a complete abandonment of the user experience in favor of a bankruptcy placeholder. It is the architectural equivalent of a Closed sign hanging on a building that is still playing its grand opening commercial on a loop.
Remove all H1 elements that claim active medicine development or recruitment to align with the current operational status. Replace the 100% identical sub-page content with unique data relevant to creditors, former patients, and stakeholders. Add direct outbound links to the GBM AGILE clinical trial registration and published peer-reviewed data to substantiate the Tinostamustine news. Update the Organization schema to reflect the transition to Knoa Pharma and include sameAs links to official Kroll restructuring documents to provide a clear proof path.
The site aligns with the Pharma and Biotech industry through its news items regarding Tinostamustine and the GBM AGILE clinical trial. However, the primary focus is now restructuring and bankruptcy, shifting the functional industry categorization toward legal and administrative receivership.
“The score was primarily driven by the extreme Semantic Coherence failure, specifically the 100% duplication of content across all sub-pages which represents maximum semantic drift. Information Density also scored high due to the persistence of legacy marketing fluff that contradicts the current news of the company's closure. Trust and Proof gaps are significant as the site uses review counts and trust theatre flags without any verifiable third-party evidence or external clinical links.”
This training module utilizes a snapshot of public data from Purdue Pharma L.P., captured on June 19, 2026, to demonstrate how machine logic evaluates different types of business narratives.
Purpose: This data is presented under “Fair Use” / “Educational Exception” for the purpose of forensic semantic analysis, allowing users to compare human intuition against machine-generated evaluations.
Notice to Purdue Pharma L.P.: This analysis is part of a non-adversarial audit conducted by 1 Euro SEO. The results provided by 1EuroSEO are intended as professional feedback to help improve any website’s machine-readability and authority signals. The 1EuroSEO BS Detection Tool is a free tool, and anyone can test any company to see how their content is interpreted by AI models.
Any company can use the insights for free and improve its voice by comparing it to industry clichés or competitors. When a company has updated its content, it can always submit a new audit request, which will be reflected in a new current score.
To all users: You are encouraged to visit the live site at https://purduepharma.com to view the most current version of its content and learn from the source what this company is about and what it offers.